Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cognis Licenses New Ingredients from InterMed - Nutraceuticals World
Market Updates

Cognis Licenses New Ingredients from InterMed

Continuing a strategic cooperation, Cognis has licensed two new active ingredients for weight management and cognitive performance from InterMed Discovery (IMD), further expanding the company’s innovation pipeline.

During their ongoing collaboration, Cognis and IMD have utilized IMD’s database of biologically active natural substances and its unique IMD Bioprofiling technology platform to discover innovative functional ingredients for specific food applications, and to bring suitable active substances to market-readiness.

One of the candidates is a new ingredient that is showing promising benefits for weight management in different test systems. The second new ingredient is a product for improving brain health, as in vivo tests have shown potential on cognitive performance. Cognis plans to carry out further in vivo tests and research studies for these ingredients later this year.

Cognis has already licensed four other ingredients from IMD targeting weight management and heart health. Clinical studies for one of these projects will begin later this year. The other licensed ingredients are currently in advanced preclinical testing and scale-up process.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters